Schedule 13G ownership disclosure

PHARMING GROUP NV

Security class unavailable · CUSIP: 71716E105

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
38,496,391
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-001537
Form type
SC 13G
Filer
Pharming Group N.V.
CIK
CIK 1828316
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub